Our previous studies have suggested that the covalent binding of acetaldehyde to proteins may be responsible for the hepatotoxicity of ethanol. These proposed studies will continue to explore this possibility and, in this regard, the following hypothesis has been formulated: During ethanol oxidation in the liver, acetaldehyde forms stable adducts via binding to """"""""reactive"""""""" lysine residues of preferential target proteins; and such binding results in impaired function of these proteins, leading eventually to liver cell injury. The initial objective is to clarify the chemistry of stable binding of acetaldehyde to proteins. By using a previously developed HPLC technique, we intend to establish the identities of the modified amino acid (lysine) residues responsible for stable binding and to determine their structures. In addition, we intend to establish the identity of the major acetaldehyde-lysine adduct(s) formed in the liver during ethanol oxidation and develop a reliable assay for detecting this adduct(s).
A second aim will utilize a hepatocyte culture model to study adduct formation and degradation over extended time periods in order to obtain information concerning the turnover of adducts in the liver. Using this model, we will also initiate studies, correlating the presence of adducts with cell viability and hepatocyte function. As an initial attempt to establish a role of stable adducts in liver injury, a third aim will investigate whether differences exist in adduct formation and/or turnover in periportal versus perivenous hepatocytes since the latter are more susceptible to ethanol-induced injury. A fourth objective will be to study the effects of stable acetaldehyde binding on the function of actin and microsomal drug metabolism since both of these models contain essential and reactive lysine residues. These two systems could be potential targets of acetaldehyde binding in the liver, and by accomplishing detailed studies with these two specific systems, we hope to provide the rationale to look for other key targets of binding. Finally, we hope to confirm the presence of stable acetaldehyde-protein adducts in the liver (or other organs) of chronically ethanol-fed rats, and to firmly establish the identity of the """"""""in vivo"""""""" lysine-acetaldehyde adduct. Correlations between evidence of liver injury and the presence of adducts will also be attempted in this model. These proposed studies hopefully will give valuable information concerning the basic molecular mechanisms of alcohol-induced hepatotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA004961-12
Application #
2043076
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1981-05-01
Project End
1993-04-30
Budget Start
1992-05-01
Budget End
1993-04-30
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Duryee, Michael J; Freeman, Thomas L; Willis, Monte S et al. (2005) Scavenger receptors on sinusoidal liver endothelial cells are involved in the uptake of aldehyde-modified proteins. Mol Pharmacol 68:1423-30
Duryee, Michael J; Willis, Monte S; Freeman, Thomas L et al. (2004) Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity. Front Biosci 9:3145-55
Tuma, Dean J; Casey, Carol A (2003) Dangerous byproducts of alcohol breakdown--focus on adducts. Alcohol Res Health 27:285-90
Duryee, Michael J; Klassen, Lynell W; Freeman, Thomas L et al. (2003) Chronic ethanol consumption impairs receptor-mediated endocytosis of MAA-modified albumin by liver endothelial cells. Biochem Pharmacol 66:1045-54
Kharbanda, Kusum K; Shubert, Kris A; Wyatt, Todd A et al. (2002) Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells. Biochem Pharmacol 63:553-62
Kharbanda, K K; Todero, S L; Shubert, K A et al. (2001) Malondialdehyde-acetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. Alcohol 25:123-8
Schaffert, C S; Sorrell, M F; Tuma, D J (2001) Expression and cytoskeletal association of integrin subunits is selectively increased in rat perivenous hepatocytes after chronic ethanol administration. Alcohol Clin Exp Res 25:1749-57
Tuma, D J; Kearley, M L; Thiele, G M et al. (2001) Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chem Res Toxicol 14:822-32
Rolla, R; Vay, D; Mottaran, E et al. (2000) Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31:878-84
McVicker, B L; Tuma, D J; Casey, C A (2000) Hyperphosphorylation of the asialoglycoprotein receptor in isolated rat hepatocytes following ethanol administration. Biochem Pharmacol 60:343-51

Showing the most recent 10 out of 68 publications